Skip to content

Irostat.

Descriptive study to evaluate the iron status in young healthy children from the Netherlands.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22896
Enrollment
400
Registered
2010-12-02
Start date
2011-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron deficiency iron deficiency anaemia young healthy children from the Netherlands

Interventions

During insertion of a peripheral intraveneus catheter, 2 cc of whole blood will be collected for analysis of the iron status. Demographic, dietary and medical information will be collected.

Sponsors

HAGA ziekenhuis / Juliana Kinderziekenhuis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female subjects, aged 6-36 months undergoing elective surgery; 2. General anesthaesia induced by intravenous injection; 3. Stable health status and expected to remain stable; 4. Written informed consent from parents/guardian.

Exclusion criteria

Exclusion criteria: 1. Known infection in the last 4 weeks; 2. Oncologic disorder; 3. Acute or chronic illness; 4. Congenital malformations; 5. Chronic or inhereted metabolic disease; 6. Premature at birth (<32 weeks); 7. Hemoglobinopathies; 8. Use of iron supplementation less than 6 weeks prior to operation; 9. Blood transfusion in the last 6 months.

Design outcomes

Secondary

MeasureTime frame
To define whether following factors contribute to iron deficiency during childhood: 1. Iron status at birth (maternal iron status/anaemia, smoking during pregnancy, preeclampsia, lower gestational age and lower birth weight); 2. Postnatal needs for iron (more rapid growth); 3. Bioavailable iron (more cow milk); 4. Sex; 5. Ethnicity (European versus non-European); 6. Socioeconomic status; 7. BMI; 8. Attending day-care.

Primary

MeasureTime frame
1. Iron status; 2. Serum haemoglobin; 3. Mean cell volume and serum ferritin; 4. Reticulocyte hemoglobin content.

Contacts

Public ContactLieke Uijterschout

Juliana Kinderziekenhuis Sportlaan 600

l.uijterschout@hagaziekenhuis.nl+31 (0)70 2100000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)